XML 31 R13.htm IDEA: XBRL DOCUMENT
v3.20.2

Accrued Liabilities | 12 Months Ended
--- | ---
Jun. 30, 2020
Accrued Liabilities, Current [Abstract] |
Accrued Liabilities | Note 7. Accrued Liabilities Accrued liabilities consisted of the following, in thousands:
|  | June 30, |
|  | 2020 |  |  | 2019 |
Accrued pre-clinical and clinical trial expenses |  | $ | 2,343 |  |  | $ | 2,014 |
Accrued compensation and benefits |  |  | 3,410 |  |  |  | 1,973 |
Accrued legal and professional services expenses |  |  | 226 |  |  |  | 316 |
Other |  |  | 111 |  |  |  | 256 |
Total accrued liabilities |  | $ | 6,090 |  |  | $ | 4,559 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration